RelB Recombinant Antibody, PE-Cy7 Conjugated
Product Specifications
Background
NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52.
Synonyms
IREL; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; relB; Transcription factor RelB.
Gene ID
5971
Swiss Prot
Q01201
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse
Target
RelB
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human RelB
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5971
Predicted Cross Reactivity
Rat
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9025515-01 0.02 mg
Virus-Like Particle (VLP) isotype control-mCherry Fluorescent
Sign In for Pricing
View Details 
MBS9025515-02 0.1 mg
Virus-Like Particle (VLP) isotype control-mCherry Fluorescent
Sign In for Pricing
View Details 
MBS9025515-03 1 mg
Virus-Like Particle (VLP) isotype control-mCherry Fluorescent
Sign In for Pricing
View Details Z7020029 5 Slides
Esophageal Tumor Tissue Array - Duplicated 36 cases of esophageal cancer and 12 cases of normal and other non-malignant
Sign In for Pricing
View Details 